Ajeya Nandi

Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling

Snahlata Singh, Sushil Kumar, Ratnesh K. Srivastava et al. · Nature Cell Biology · 2020 · 105 citations · Full text

Breast Oncology, Signaling Pathway, Medicine +11

Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway

Sushil Kumar, Ajeya Nandi, Snahlata Singh et al. · Nature Communications · 2021 · 79 citations · Full text

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells

Kevin Wang, Paulina Coutifaris, David Brocks et al. · Cancer Cell · 2024 · 73 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, T-regulatory Cell +10

Immature natural killer cells promote progression of triple-negative breast cancer

Gatha Thacker, Samantha Henry, Ajeya Nandi et al. · Science Translational Medicine · 2023 · 72 citations · Full text

Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer

Ajeya Nandi, Rahul Debnath, Anupma Nayak et al. · Cancer Research · 2022 · 35 citations · Full text